Clinical Trials Browser

Phase NA × Carcinoma, Hepatocellular × tislelizumab × Clear all

NCT07243691 2025-11-24

Study on the Therapeutic Effect of Different Infusion Times of Tislelizumab on Postoperative High-risk Hepatocellular Carcinoma

Phase NA Recruiting

Gastrointestinal

Carcinoma, Hepatocellular

NCT05339581 2022-04-27

iPLENTY-pvtt

Phase NA Unknown

Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms

NCT05277675 2022-03-14

RANT

Phase NA Unknown

Gastrointestinal

Carcinoma, Hepatocellular, Recurrence